title: A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia.
authors.forename: E
authors.initials: E
authors.lastname: Estey
authors.forename: S
authors.initials: S
authors.lastname: Kornblau
authors.forename: S
authors.initials: S
authors.lastname: Pierce
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
authors.forename: M
authors.initials: M
authors.lastname: Beran
authors.forename: M
authors.initials: M
authors.lastname: Keating
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D001499:Bayes Theorem; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D018572:Disease-Free Survival; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D018579:Patient Selection; D011379:Prognosis; D011446:Prospective Studies; D012074:Remission Induction; D016879:Salvage Therapy; D016896:Treatment Outcome